quick search
Today:
Home Manufacturing

More Articles

Embrace Autumn Outdoor Activities: Renowned Traditional Chinese Medicine Expert Professor Tinly Wong Tin-Chee Offers Effective Solutions for Relieving Post-Exercise Muscle Soreness with Massage, Herbal Oils, and Plasters

Nov 4, 2024

HONG KONG,Nov. 4,2024-- As autumn settles in and temperatures begin to drop,many individuals embrace outdoor activities such as running,cycling,and hiking,delighting in the beauty of nature. However,

Telix Welcomes CMS Decision to Improve Payments for Diagnostic Radiopharmaceuticals

Nov 4, 2024

MELBOURNE,Australia,Nov. 4,2024-- Telix Pharmaceuticals Limited (ASX: TLX,Telix,the Company) today welcomes the announcement by the United States (U.S.) Centers for Medicare & Medicaid Services (

Xtend Reports Record 113% Revenue Growth in First Half of 2024/2025 Fiscal Year, Fueled by Global Expansion and Advanced AI Innovations

Nov 4, 2024

SINGAPORE,Nov. 4,2024-- Xtend,a leading AI-powered digital marketing company,has announced record financial results for the first half of the 2024/2025 fiscal year,achieving a remarkable 113% increase

TECNO Pocket Go Named to TIME'S List of The Best Inventions of 2024

Nov 1, 2024

HONG KONG,Oct. 31,2024-- Global innovative technology brandTECNO today shared that its innovative TECNO Pocket Go has been listed as one of TIME\'s Best Inventions of 2024 by TIME.

NTT Sparks Collaboration on AI, Drives Smart City Development at Innovation Summit

Nov 1, 2024

Sophia,the local humanoid,shines at the Summit,sparking excitement for Hong Kong\'s smart city future.

Global Times: 15 years on, China's Nasdaq-style ChiNext board drives innovative economic growth

Nov 1, 2024

BEIJING,Oct. 31,2024-- Wednesday marked the 15th anniversary of theChiNext board,a Nasdaq-style board for growth enterprises in China,which opened for trading on October 30,2009. After 15 years of rap

CStone Announces MHRA Approval of Sugemalimab for First-Line Treatment of Non-Small Cell Lung Cancer (NSCLC) in the UK

Nov 1, 2024

This approval marks the second international marketing authorization forsugemalimab outside of China,following its recent approval by the European Commission.

Cancer trial: retraining immune cells offers new hope for patients in personalized medicine breakthrough

Nov 1, 2024

BOSTON,Oct. 31,2024-- In a remarkable development for cancer research,patients with advanced-stage cancer have benefited fromSUPLEXA,a personalized treatment that trains the patient\'s own immune cel

J-Stories to start featuring articles from Tokyo Updates, a web magazine highlighting Tokyo's latest developments, to share the city's unique innovative projects and ideas with a global audience.

Nov 1, 2024

Japan\'s solutions-focused news platform collaborates with Tokyo\'s official information service to help disseminate Japan\'s innovative insights to international audiences

Yaber's Award-Winning K3 Projector Available on Amazon on November 4th, 2024

Nov 1, 2024

NEW YORK,Oct. 31,2024--Yaber,a pioneer in entertainment projectors,is thrilled to announce the global launch of its latest K3 Projector,available on Amazon starting November 4,2024. This next-generat

1 ... 69 70 71 72 73 74 75 ... 118

Quick Search

Official Affairs is a reliable source for the latest regional news, corporate updates, and official announcements, providing unbiased reporting and in-depth insights into corporate affairs.

© OfficialAffairs